Aria CV’s second-generation medical device for treating people with pulmonary arterial hypertension (PAH) — a balloon system…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
A research project to help shed light about why people with the human immunodeficiency virus (HIV) are at…
Sensydia announced that it successfully completed a fifth study of its investigative Cardiac Performance System (CPS), intended to…
Four microRNAs (miRNAs) — small RNA molecules that regulate protein production — were found at different levels in blood samples…
In people with pulmonary arterial hypertension (PAH), treatment with the novel cell therapy CAP-1002 was safe and showed encouraging…
INOmax EVOLV DS, a device to deliver nitric oxide gas by inhalation to newborns with pulmonary hypertension (PH),…
The noninvasive CPET test — known in full as cardiopulmonary exercise testing, which determines how the heart responds to exercise…
A professor of pediatric cardiology at Stanford University School of Medicine will receive the American Heart Association 2023 Research Achievement…
Higher pressure in the heart’s top left chamber — a parameter called pulmonary arterial wedge pressure (PAWP) — is a…
Triple combination therapy — used to target multiple pathways — improves lung and heart function in pulmonary arterial hypertension…
An echocardiogram during pregnancy, particularly at the third trimester, may help in predicting a risk of persistent pulmonary hypertension…
Inhaled nitric oxide (iNO) therapy reduces the risk of death in preterm infants with severe hypoxemic respiratory failure (HRF) —…